Northland Capmk Weighs in on Enovix FY2026 Earnings

Enovix Co. (NASDAQ:ENVX) – Stock analysts at Northland Capmk issued their FY2026 earnings per share (EPS) estimates for shares of Enovix in a note issued to investors on Friday, November 22nd. Northland Capmk analyst G. Richard forecasts that the company will post earnings per share of ($0.65) for the year. The consensus estimate for Enovix’s current full-year earnings is ($1.17) per share.

Enovix (NASDAQ:ENVX) last released its earnings results on Tuesday, October 29th. The company reported ($0.17) EPS for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.03. Enovix had a negative return on equity of 102.19% and a negative net margin of 1,180.21%. The company had revenue of $4.30 million for the quarter, compared to the consensus estimate of $4.11 million. During the same quarter last year, the business posted ($0.27) EPS.

Several other brokerages also recently issued reports on ENVX. Piper Sandler reissued an “overweight” rating and issued a $19.00 price target (down previously from $23.00) on shares of Enovix in a report on Monday, August 5th. Benchmark reissued a “buy” rating and issued a $25.00 price target on shares of Enovix in a report on Wednesday, October 30th. Craig Hallum raised their price target on Enovix from $15.00 to $20.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. Cantor Fitzgerald reissued an “overweight” rating and issued a $30.00 price target on shares of Enovix in a report on Wednesday, October 30th. Finally, JPMorgan Chase & Co. cut their price target on Enovix from $18.00 to $15.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. Two analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $20.50.

Enovix Trading Down 3.3 %

Shares of NASDAQ ENVX opened at $9.22 on Monday. The company has a market cap of $1.64 billion, a price-to-earnings ratio of -5.73 and a beta of 1.99. Enovix has a 12-month low of $5.70 and a 12-month high of $18.68. The company has a current ratio of 3.77, a quick ratio of 3.61 and a debt-to-equity ratio of 0.99. The stock’s 50 day simple moving average is $10.00 and its 200 day simple moving average is $11.31.

Hedge Funds Weigh In On Enovix

Several hedge funds have recently modified their holdings of ENVX. Driehaus Capital Management LLC increased its position in shares of Enovix by 63.7% during the 2nd quarter. Driehaus Capital Management LLC now owns 3,886,492 shares of the company’s stock valued at $60,085,000 after purchasing an additional 1,512,424 shares during the period. Fred Alger Management LLC increased its position in shares of Enovix by 2,468.6% during the 3rd quarter. Fred Alger Management LLC now owns 588,614 shares of the company’s stock valued at $5,498,000 after purchasing an additional 565,698 shares during the period. Old West Investment Management LLC grew its holdings in shares of Enovix by 47.6% in the 2nd quarter. Old West Investment Management LLC now owns 835,386 shares of the company’s stock worth $12,915,000 after acquiring an additional 269,371 shares during the last quarter. Sora Investors LLC grew its holdings in shares of Enovix by 75.0% in the 3rd quarter. Sora Investors LLC now owns 525,000 shares of the company’s stock worth $4,904,000 after acquiring an additional 225,000 shares during the last quarter. Finally, Barclays PLC grew its holdings in shares of Enovix by 376.9% in the 3rd quarter. Barclays PLC now owns 252,012 shares of the company’s stock worth $2,353,000 after acquiring an additional 199,166 shares during the last quarter. 50.92% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Arthi Chakravarthy sold 35,000 shares of Enovix stock in a transaction on Monday, October 14th. The stock was sold at an average price of $13.00, for a total transaction of $455,000.00. Following the transaction, the insider now directly owns 343,305 shares in the company, valued at approximately $4,462,965. This trade represents a 9.25 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 15.70% of the stock is owned by insiders.

About Enovix

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.